NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMA -- SCHEDULE 13D/A(#1)

Company

OnKure Therapeutics, Inc.

Filed

May 8, 2024

Accession Number

0001072613-24-000437